1-(4-Aminopiperidin-1-yl)propan-2-one is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive compounds, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into molecules designed to interact with specific receptors in the brain, making it valuable for creating potential drugs for conditions like depression, anxiety, and schizophrenia. Additionally, it is explored in the development of analgesics and anti-inflammatory agents due to its ability to modulate pain pathways. Researchers also investigate its role in designing compounds with potential anticancer properties, leveraging its chemical framework to enhance drug efficacy and selectivity.